Glucose 10% - Queensland Ambulance Service

Drug Therapy Protocols: Glucose 10%
Disclaimer and copyright
©2016 Queensland Government
All rights reserved. Without limiting the reservation of copyright, no person shall reproduce, store in a
retrieval system or transmit in any form, or by any means, part or the whole of the Queensland Ambulance
Service (‘QAS’) Clinical practice manual (‘CPM’) without the priorwritten permission of the Commissioner.
The QAS accepts no responsibility for any modification, redistribution or use of the CPM or any part
thereof. The CPM is expressly intended for use by QAS paramedics whenperforming duties and delivering
ambulance services for, and on behalf of, the QAS.
Under no circumstances will the QAS, its employees or agents, be liable for any loss, injury, claim, liability
or damages of any kind resulting from the unauthorised use of, or reliance upon the CPM or its contents.
While effort has been made to contact all copyright owners this has not always been possible. The QAS
would welcome notification from any copyright holder who has been omitted or incorrectly acknowledged.
All feedback and suggestions are welcome, please forward to:
[email protected]
Date
October, 2015
Purpose
Scope
Author
To ensure a consistent procedural approach to Glucose 10% administration.
Applies to all QAS clinical staff.
Clinical Quality & Patient Safety Unit, QAS
Review date
October, 2017
URL
https://ambulance.qld.gov.au/clinical.html
This work is licensed under the Creative Commons
Attribution-NonCommercial-NoDerivatives 4.0
International License. To view a copy of this license,
visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Glucose 10%
October, 2015
Drug class
Side effects
Hyperglycaemic
UNCONTROLLED WHEN PRINTED
Pharmacology
• Nil
Glucose is a sugar that is the principal energy source for body cells,
especially the brain.[1]
Metabolism
Presentation
Broken down in most tissues and distributed throughout total body water.[2] • Viaflex® plastic container, 250 mL glucose 10% (25 g)
UNCONTROLLED WHEN PRINTED
Indications
• Symptomatic hypoglycaemia (with the inability to self-administer oral glucose)
Onset
Duration
Half-life
Rapid
Not applicable
Not applicable
UNCONTROLLED WHEN PRINTED
Contraindications
Schedule
• Unscheduled.
Intravenous infusion (IV INF )
CCP
Routes of administration
ACP2
• Nil
• Hyperglycaemia
Intraosseous infusion (IO INF )
CCP
UNCONTROLLED WHEN PRINTED
Precautions
Figure 4.16
QUEENSLAND AMBULANCE SERVICE
761
Glucose 10%
October, 2015
Adult dosages
Special notes
UNCONTROLLED WHEN PRINTED
Symptomatic hypoglycaemia
CCP
ACP2
(with the inability to self administer oral glucose)
IV
INF
15 g (150 mL)
Repeated at 100 mL (10 g) boluses every 5 minutes until BGL > 4.0 mmol/L.
• Glucose 10% is the preferred treatment for hypoglycaemia for patients unable to take oral glucose. This is due to its rapid onset and ability to quickly restore blood glucose
concentration to normal values.[2]
CCP
UNCONTROLLED WHEN PRINTED
IO
INF
15 g (150 mL)
Repeated at 100 mL (10 g) boluses every 5 minutes until BGL > 4.0 mmol/L.
Paediatric dosages
UNCONTROLLED WHEN PRINTED
Symptomatic hypoglycaemia
CCP
ACP2
(with the inability to self administer oral glucose)
IV
INF
0.25 g/kg (2.5 mL/kg)
Repeated at 1 mL/kg (0.1 g/kg) boluses every 5 minutes until BGL > 4.0 mmol/L.
IO
INF
0.25 g/kg (2.5 mL/kg)
Repeated at 1 mL/kg (0.1 g/kg) boluses every 5 minutes until BGL > 4.0 mmol/L.
CCP
UNCONTROLLED WHEN PRINTED
QUEENSLAND AMBULANCE SERVICE
762